Pereira Brian JG 4

What Happened
Brian JG Pereira, a director of ProKidney Corp. (ticker: PROK), was granted a derivative award of 135,000 shares (reported as options) on 2026-05-28. The filing reports an acquisition at a $0.00 price (total reported value $0), indicating a compensatory grant rather than a market purchase.

Key Details

• Transaction date: 2026-05-28 (Form 4 filed 2026-05-29). Filing appears timely.
• Instrument: Derivative award (options) for 135,000 shares; reported price per share $0.00; total reported value $0.
• Grant source: Issuer's non‑employee director compensation policy (footnote F1).
• Vesting: Options vest in full on the earlier of the one‑year anniversary of the grant or the company’s next annual general shareholder meeting (footnote F2).
• Shares owned after transaction: Not specified in the summary filing (check the full Form 4 for holdings).
• Transaction code: A = Award/Grant.

Context
This was a compensation grant to a non‑employee director, not an open‑market purchase or sale. Such grants are routine for board members and reflect compensation, not necessarily a personal cash investment or immediate sign of insider buying/selling. The award will only produce shares for Pereira if and when the vesting conditions are met (likely within a year).